Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression [NA]

View source ↗

Summary

A completed clinical trial update investigating neural correlates of ketamine's anti-suicidal effects in bipolar depression.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Centre for Addiction and Mental Health | Conditions: Bipolar Disorder (BD), Suicidality | NA | Status: COMPLETED